Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 35 citing articles:

Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics
Zong Sheng Guo, Binfeng Lu, Zongbi Guo, et al.
Journal for ImmunoTherapy of Cancer (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 250
The Status of Vaccine Development Against the Human Cytomegalovirus
Stanley A. Plotkin, Dai Wang, Abdel Oualim, et al.
The Journal of Infectious Diseases (2019) Vol. 221, Iss. Supplement_1, pp. S113-S122
Open Access | Times Cited: 95
Development of a multi-antigenic SARS-CoV-2 vaccine candidate using a synthetic poxvirus platform
Flavia Chiuppesi, Marcela D Salazar, Heidi Contreras, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 94
Human Cytomegalovirus Cell Tropism and Host Cell Receptors
Giuseppe Gerna, Anna Kabanova, Daniele Lilleri
Vaccines (2019) Vol. 7, Iss. 3, pp. 70-70
Open Access | Times Cited: 81
Synthetic multiantigen MVA vaccine COH04S1 protects against SARS-CoV-2 in Syrian hamsters and non-human primates
Flavia Chiuppesi, Vu H. Nguyen, Yoonsuh Park, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 51
A fifty-year odyssey: prospects for a cytomegalovirus vaccine in transplant and congenital infection
Don J. Diamond, Corinna La Rosa, Flavia Chiuppesi, et al.
Expert Review of Vaccines (2018) Vol. 17, Iss. 10, pp. 889-911
Open Access | Times Cited: 50
A randomised, placebo-controlled phase 3 study to evaluate the efficacy and safety of ASP0113, a DNA-based CMV vaccine, in seropositive allogeneic haematopoietic cell transplant recipients
Per Ljungman, Arancha Bermúdez, Aaron C. Logan, et al.
EClinicalMedicine (2021) Vol. 33, pp. 100787-100787
Open Access | Times Cited: 24
A multivalent Kaposi sarcoma-associated herpesvirus-like particle vaccine capable of eliciting high titers of neutralizing antibodies in immunized rabbits
David H. Mulama, Lorraine Z. Mutsvunguma, Jennifer Totonchy, et al.
Vaccine (2019) Vol. 37, Iss. 30, pp. 4184-4194
Open Access | Times Cited: 27
A Pentavalent Epstein-Barr Virus-Like Particle Vaccine Elicits High Titers of Neutralizing Antibodies against Epstein-Barr Virus Infection in Immunized Rabbits
Gabriela M. Escalante, Joslyn Foley, Lorraine Z. Mutsvunguma, et al.
Vaccines (2020) Vol. 8, Iss. 2, pp. 169-169
Open Access | Times Cited: 27
Immunization with Epstein–Barr Virus Core Fusion Machinery Envelope Proteins Elicit High Titers of Neutralizing Activities and Protect Humanized Mice from Lethal Dose EBV Challenge
Xinle Cui, Zhouhong Cao, Yuriko Ishikawa, et al.
Vaccines (2021) Vol. 9, Iss. 3, pp. 285-285
Open Access | Times Cited: 23
Repertoire characterization and validation of gB-specific human IgGs directly cloned from humanized mice vaccinated with dendritic cells and protected against HCMV
Sebastian J. Theobald, Christoph Kreer, Sahamoddin Khailaie, et al.
PLoS Pathogens (2020) Vol. 16, Iss. 7, pp. e1008560-e1008560
Open Access | Times Cited: 22
Hematopoietic stem cell donor vaccination with cytomegalovirus triplex augments frequencies of functional and durable cytomegalovirus‐specific T cells in the recipient: A novel strategy to limit antiviral prophylaxis
Corinna La Rosa, Ibrahim Aldoss, Yoonsuh Park, et al.
American Journal of Hematology (2023) Vol. 98, Iss. 4, pp. 588-597
Open Access | Times Cited: 7
Effects of pre-existing orthopoxvirus-specific immunity on the performance of Modified Vaccinia virus Ankara-based influenza vaccines
Arwen F. Altenburg, Stella E. van Trierum, Erwin de Bruin, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 22
Development of novel vaccines against human cytomegalovirus
Xinle Cui, Clifford M. Snapper
Human Vaccines & Immunotherapeutics (2019) Vol. 15, Iss. 11, pp. 2673-2683
Open Access | Times Cited: 21
Highly stable and immunogenic CMV T cell vaccine candidate developed using a synthetic MVA platform
Marçal Yll, Yoonsuh Park, Joy Martinez, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 2
Multivalent MVA-vectored vaccine elicits EBV neutralizing antibodies in rhesus macaques that reduce EBV infection in humanized mice
Gabriela M. Escalante, Ivana Gabriela Reidel, Lorraine Z. Mutsvunguma, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
COH04S1 and beta sequence-modified vaccine protect hamsters from SARS-CoV-2 variants
Felix Wussow, Mindy Kha, Katelyn Faircloth, et al.
iScience (2022) Vol. 25, Iss. 6, pp. 104457-104457
Open Access | Times Cited: 10
Dense Bodies of a gH/gL/UL128/UL130/UL131 Pentamer-Repaired Towne Strain of Human Cytomegalovirus Induce an Enhanced Neutralizing Antibody Response
Caroline Lehmann, Jessica Falk, Nicole Büscher, et al.
Journal of Virology (2019) Vol. 93, Iss. 17
Open Access | Times Cited: 16
In Utero Human Cytomegalovirus Infection Is Associated With Increased Levels of Putatively Protective Maternal Antibodies in Nonprimary Infection: Evidence for Boosting but Not Protection
Jeffrey R. Dorfman, Sashkia R. Balla, Jayani Pathirana, et al.
Clinical Infectious Diseases (2021) Vol. 73, Iss. 4, pp. e981-e987
Closed Access | Times Cited: 14
A vaccine to prevent initial loss of cognition and eventual Alzheimer's disease in elderly persons
Jeffrey Fessel
Alzheimer s & Dementia Translational Research & Clinical Interventions (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 13
Modeling Human Cytomegalovirus in Humanized Mice for Vaccine Testing
Johannes Koenig, Sebastian J. Theobald, Renata Stripecke
Vaccines (2020) Vol. 8, Iss. 1, pp. 89-89
Open Access | Times Cited: 14
Development of a Synthetic Poxvirus-Based SARS-CoV-2 Vaccine
Flavia Chiuppesi, Marcela D Salazar, Heidi Contreras, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 14
Evasion of the Host Immune Response by Betaherpesviruses
Daniel Sausen, Kirstin Reed, Maimoona Bhutta, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7503-7503
Open Access | Times Cited: 12
MVA-Vectored Pentameric Complex (PC) and gB Vaccines Improve Pregnancy Outcome after Guinea Pig CMV Challenge, but Only gB Vaccine Reduces Vertical Transmission
Heidi Contreras, Felix Wussow, Claudia Fernández-Alarcón, et al.
Vaccines (2019) Vol. 7, Iss. 4, pp. 182-182
Open Access | Times Cited: 12
Modified vaccinia Ankara expressing EEHV1A glycoprotein B elicits humoral and cell-mediated immune responses in mice
Taylor Pursell, Jennifer L. Spencer Clinton, Jie Tan, et al.
PLoS ONE (2022) Vol. 17, Iss. 3, pp. e0265424-e0265424
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top